Best Earnings Power Value Diagnostics & Research Stocks 2026

Top Diagnostics & Research stocks by Earnings Power Value (EPV) upside in 2026. Greenwald-framework valuation updated daily from SEC filings.

32 stocks analyzed Updated 2026-05-29
# Ticker Company QOC Price EPV Upside
1 MYGN Myriad Genetics, Inc. 6.6 $4.22 +293.9%
2 XGN Exagen Inc. 6.3 $5.08 +43.0%
3 FLGT Fulgent Genetics, Inc. 7.1 $18.24 +32.2%
4 ICLR ICON plc 2.4 $136.80 +23.9%
5 FONR Fonar Corporation 8.3 $19.09 +12.6%
6 CRL Charles River Laboratories Inte 7.8 $181.34 -14.9%
7 ILMN Illumina, Inc. 8.5 $158.70 -17.3%
8 QGEN Qiagen N.V. 2.4 $36.64 -40.7%
9 NEO NeoGenomics, Inc. 6.8 $10.19 -41.0%
10 RVTY Revvity, Inc. 8.2 $101.22 -44.6%
11 N••• Natera, ••••• •.• $•••.•• ••.•%
12 L••• Labcorp ••••• •.• $•••.•• ••.•%
13 P••• Prenetics ••••• •.• $•••.•• ••.•%
14 P••• Personalis, ••••• •.• $•••.•• ••.•%
15 I••• Insight ••••• •.• $•••.•• ••.•%
16 V••• Veracyte, ••••• •.• $•••.•• ••.•%
17 A••• Agilent ••••• •.• $•••.•• ••.•%
18 I••• IDEXX ••••• •.• $•••.•• ••.•%
19 M••• Mettler-Toledo ••••• •.• $•••.•• ••.•%
20 B••• Burning ••••• •.• $•••.•• ••.•%
🔒

Unlock the Full Best Earnings Power Value Diagnostics & Research Stocks 2026 List

Screen all 32 Diagnostics & Research stocks with 13 institutional-grade valuation models. Updated daily from SEC EDGAR filings.

Access Full Screening — From $27/mo →

How CirclFi Ranks Diagnostics & Research Stocks

CirclFi analyzes 32 Diagnostics & Research stocks daily using 13 independent institutional-grade valuation models. Each model processes SEC EDGAR 10-K and 10-Q financial filings (700+ XBRL tags), FRED macroeconomic data, and GDELT news sentiment.

The best earnings power value diagnostics & research stocks 2026 ranking uses epv upside as the primary sort criterion. Models span intrinsic valuation (Bayesian DCF with 10,000 Monte Carlo simulations, EPV), scenario analysis (First Chicago), regime-switching (Markov DDM), and machine learning (ML-RIV, FTNN Topology).